The Global luxury travel market is estimated to be valued at US$ 8.95Bn in 2024 and is expected to exhibit a CAGR of 4.6% over the forecast period 2024 to 2030. Key TakeawaysKey players operating in the luxury travel market are Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian